Trafermin is a recombinant human fibroblast growth factor-2 (rhFGF-2) protein. It plays a crucial role in tissue regeneration and wound healing. Trafermin is used in the biomedical industry to promote the healing of chronic skin ulcers, such as pressure ulcers and diabetic foot ulcers. It aids in the proliferation of cells and stimulates blood vessel formation, resulting in accelerated wound closure and improved tissue repair.
Trafermin, also known as recombinant human basic fibroblast growth factor (rh-bFGF), is a bioactive protein that plays a pivotal role in cell proliferation, differentiation, and tissue regeneration. As a member of the fibroblast growth factor family, it is integral to a variety of physiological processes, including angiogenesis, wound healing, and embryonic development. Its potent mitogenic activity on a range of cell types, particularly fibroblasts and endothelial cells, makes it a valuable research tool for investigating cellular signaling pathways and tissue engineering strategies. Due to its recombinant nature, Trafermin offers a consistent and reliable source of bFGF for experimental applications in molecular biology, cell culture, and regenerative medicine research.
Cell culture supplementation: Trafermin is widely utilized as a growth supplement in in vitro cell culture systems to promote the proliferation and maintenance of primary cells, stem cells, and various cell lines. Its addition to culture media can significantly enhance the expansion of mesenchymal stem cells, neural progenitor cells, and fibroblasts by activating key signaling cascades involved in cell cycle progression. Researchers commonly employ it to maintain the undifferentiated state of pluripotent stem cells or to boost the growth rate of slow-proliferating cell populations, thereby improving the efficiency and reproducibility of cell-based assays.
Tissue engineering and regenerative research: In the context of tissue engineering, recombinant bFGF serves as a critical component for stimulating cell migration, extracellular matrix production, and neovascularization within engineered constructs. Its capacity to enhance the formation of new blood vessels and support the integration of biomaterials makes it indispensable in the development of scaffolds for skin, bone, and vascular tissue regeneration. By incorporating Trafermin into biomaterial matrices or delivery systems, investigators can modulate the local microenvironment to accelerate tissue repair and functional recovery in preclinical models.
Angiogenesis studies: The protein's robust angiogenic activity underpins its frequent use in experimental models designed to elucidate mechanisms of blood vessel formation and remodeling. Trafermin induces endothelial cell proliferation, migration, and differentiation, all of which are fundamental processes in the development of new capillary networks. Researchers utilize it to study vascular morphogenesis, screen for pro- or anti-angiogenic compounds, and explore the interplay between growth factors and cellular responses during neovascularization.
Signal transduction research: Trafermin enables detailed investigation into fibroblast growth factor receptor (FGFR)-mediated signaling pathways. By activating FGFRs on target cells, it triggers downstream cascades such as the MAPK/ERK and PI3K/AKT pathways, which govern cell survival, proliferation, and differentiation. Use of this recombinant protein in biochemical assays or phosphoproteomic studies allows for precise dissection of receptor-ligand interactions, kinase activation events, and regulatory feedback mechanisms within the FGF signaling network.
Wound healing models: The mitogenic and chemotactic properties of bFGF have made Trafermin a standard tool in in vitro and in vivo models of wound repair. It is commonly applied to study the cellular and molecular dynamics of re-epithelialization, granulation tissue formation, and matrix remodeling. Through its effects on fibroblasts, keratinocytes, and endothelial cells, Trafermin facilitates the investigation of factors influencing tissue regeneration, scar formation, and the efficacy of candidate wound-healing agents under controlled laboratory conditions.
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More